83 FR 53488 - National Institute of Neurological Disorders and Stroke

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 205 (October 23, 2018)

Page Range		53488-53489
FR Document		2018-23032

Federal Register, Volume 83 Issue 205 (Tuesday, October 23, 2018)

[Federal Register Volume 83, Number 205 (Tuesday, October 23, 2018)]
[Notices]
[Pages 53488-53489]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-23032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of an Interagency Pain Research 
Coordinating Committee (IPRCC) meeting.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Interagency Pain Research Coordinating 
Committee.
    Date: November 16, 2018.
    Time: 8:30 a.m. to 5:00 p.m. *Eastern Time*--Approximate end 
time.
    Agenda: The meeting will include discussions of committee 
business items including an updated Federal Pain Portfolio Analysis, 
an update on the Federal Pain Research Strategy and information 
about the NIH HEAL Initiative.
    Place: National Institutes of Health, Building 35 A, Porter 
Neuroscience Center, Room 620/630, 35 Convent Drive, Bethesda, MD 
20892.
    Webcast Live: http://videocast.nih.gov/.
    Deadlines: Submission of intent to submit written/electronic 
statement for comments: Friday, November 2, 2018. Submission of 
written/electronic statement for oral comments: Friday, November 9, 
2018.
    Contact Person: Linda L. Porter, Ph.D., Director, Office of Pain 
Policy & Planning, Office of the Director, National Institute of

[[Page 53489]]

Neurological Disorders and Stroke, NIH, 31 Center Drive, Room 8A31, 
Bethesda, MD 20892, Phone: (301) 451-4460, Email: 
Linda.Porter@nih.gov.

    Please Note: Any member of the public interested in submitting 
written comments to the Committee must notify the Contact Person 
listed on this notice by 5:00 p.m. ET on Friday, November 2, 2018, 
with their request. Interested individuals and representatives of 
organizations must submit a written/electronic copy of the oral 
statement/comments including a brief description of the organization 
represented by 5:00 p.m. ET on Friday, November 9, 2018. Statements 
submitted will be shared with the committee members and become a 
part of the public record.
    The meeting will be open to the public and accessible by live 
Webcast. Individuals who participate in person or by using these 
electronic services and who need special assistance, such as 
captioning or other reasonable accommodations, should submit a 
request to the Contact Person listed on this notice at least seven 
days prior to the meeting.
    As a part of security procedures, attendees should be prepared 
to present a photo ID during the security process to get on the NIH 
campus. For a full description, please see: http://www.nih.gov/about/visitorsecurity.htm.
    Information about the IPRCC is available on the website: http://iprcc.nih.gov/.


    Dated: October 16, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-23032 Filed 10-22-18; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 83, No. 205 / Tuesday, October 23, 2018 / Notices 53489

Neurological Disorders and Stroke, NIH, 31 Time: 1:00 p.m. to 4:30 p.m. Dated: October 17, 2018.
Center Drive, Room 8A31, Bethesda, MD Agenda: To review and evaluate grant Natasha M. Copeland,
20892, Phone: (301) 451–4460, Email: applications. Program Analyst, Office of Federal Advisory
Linda.Porter@nih.gov. Place: National Institute on Aging, Committee Policy.
Please Note: Any member of the public Gateway Building, Suite 2W200, 7201
[FR Doc. 2018–23034 Filed 10–22–18; 8:45 am]
interested in submitting written comments to Wisconsin Avenue, Bethesda, MD 20892
BILLING CODE 4140–01–P
the Committee must notify the Contact (Telephone Conference Call).
Person listed on this notice by 5:00 p.m. ET Contact Person: Isis S. Mikhail, MD, MPH,
on Friday, November 2, 2018, with their DRPH, National Institute on Aging, Gateway
request. Interested individuals and Building, 7201 Wisconsin Avenue, Suite DEPARTMENT OF HEALTH AND
representatives of organizations must submit 2C212, Bethesda, MD 20892, 301–402–7704, HUMAN SERVICES
a written/electronic copy of the oral mikhaili@mail.nih.gov.
statement/comments including a brief National Institutes of Health
description of the organization represented (Catalogue of Federal Domestic Assistance
by 5:00 p.m. ET on Friday, November 9, Program Nos. 93.866, Aging Research, Government-Owned Inventions;
2018. Statements submitted will be shared National Institutes of Health, HHS) Availability for Licensing
with the committee members and become a Dated: October 17, 2018.
part of the public record. AGENCY: National Institutes of Health,
Melanie J. Pantoja,
The meeting will be open to the public and HHS.
accessible by live Webcast. Individuals who Program Analyst, Office of Federal Advisory
ACTION: Notice.
participate in person or by using these Committee Policy.
electronic services and who need special [FR Doc. 2018–23068 Filed 10–22–18; 8:45 am] SUMMARY: The invention listed below is
assistance, such as captioning or other BILLING CODE 4140–01–P owned by an agency of the U.S.
reasonable accommodations, should submit a Government and is available for
request to the Contact Person listed on this
notice at least seven days prior to the licensing to achieve expeditious
meeting. DEPARTMENT OF HEALTH AND commercialization of results of
As a part of security procedures, attendees HUMAN SERVICES federally-funded research and
should be prepared to present a photo ID development. Foreign patent
during the security process to get on the NIH National Institutes of Health applications are filed on selected
campus. For a full description, please see: inventions to extend market coverage
http://www.nih.gov/about/ National Eye Institute; Notice of Closed for companies and may also be available
visitorsecurity.htm. Meeting for licensing.
Information about the IPRCC is available
on the website: http://iprcc.nih.gov/. Pursuant to section 10(d) of the FOR FURTHER INFORMATION CONTACT: Dr.
Federal Advisory Committee Act, as Vince Contreras, 240–669–2823;
Dated: October 16, 2018. vince.contreras@nih.gov. Licensing
amended, notice is hereby given of the
Sylvia L. Neal, following meeting. information and copies of the U.S.
Program Analyst, Office of Federal Advisory patent application listed below may be
Committee Policy. The meeting will be closed to the obtained by communicating with the
public in accordance with the indicated licensing contact at the
[FR Doc. 2018–23032 Filed 10–22–18; 8:45 am]
provisions set forth in sections Technology Transfer and Intellectual
BILLING CODE 4140–01–P
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Property Office, National Institute of
as amended. The grant applications and Allergy and Infectious Diseases, 5601
DEPARTMENT OF HEALTH AND the discussions could disclose Fishers Lane, Rockville, MD 20852; tel.
HUMAN SERVICES confidential trade secrets or commercial 301–496–2644. A signed Confidential
property such as patentable material, Disclosure Agreement will be required
National Institutes of Health and personal information concerning to receive copies of unpublished patent
individuals associated with the grant applications.
National Institute on Aging; Notice of applications, the disclosure of which
SUPPLEMENTARY INFORMATION:
Closed Meeting would constitute a clearly unwarranted
Technology description follows.
invasion of personal privacy.
Pursuant to section 10(d) of the
Name of Committee: National Eye Institute Fusion Glycoprotein Vaccine for
Federal Advisory Committee Act, as
Special Emphasis Panel; Secondary Data Human Metapneumovirus
amended, notice is hereby given of the
following meeting. Analysis (R21) Grant Applications. Description of Technology: Human
The meeting will be closed to the Date: November 19, 2018. metapneumovirus (hMPV), a negative,
public in accordance with the Time: 3:00 p.m. to 5:00 p.m. single-stranded RNA virus, accounts for
provisions set forth in sections Agenda: To review and evaluate grant approximately 5–15% of infant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications. respiratory tract infections and poses a
Place: National Institutes of Health,
as amended. The grant applications and severe risk of disease and
Rockledge 6700, 6700B Rockledge Drive,
the discussions could disclose Bethesda, MD 20817 (Telephone Conference
hospitalization in both the elderly and
confidential trade secrets or commercial Call). the immunocompromised. Investigators
property such as patentable material, Contact Person: Brian Hoshaw, Ph.D., at the Vaccine Research Center (VRC) of
and personal information concerning Scientific Review Officer, National Eye the National Institute of Allergy and
individuals associated with the grant Infectious Diseases (NIAID) have
khammond on DSK30JT082PROD with NOTICES

Institute, National Institutes of Health,
applications, the disclosure of which Division of Extramural Research, 5635 generated an hMPV fusion glycoprotein
would constitute a clearly unwarranted Fishers Lane, Suite 1300, Rockville, MD (‘‘F protein’’) stabilized in a prefusion
invasion of personal privacy. 20892, 301–451–2020, hoshawb@ conformation.
Name of Committee: National Institute on mail.nih.gov. Stabilizing this prefusion
Aging Special Emphasis Panel; NIA AD/ (Catalogue of Federal Domestic Assistance conformation of the F protein reveals an
ADRD Research Collaboratory. Program Nos. 93.867, Vision Research, immunodominant site which makes it
Date: November 20, 2018. National Institutes of Health, HHS) an ideal vaccine immunogen. The

VerDate Sep<11>2014 20:20 Oct 22, 2018 Jkt 247001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\23OCN1.SGM 23OCN1

Document Created: 2018-10-23 04:14:49
Document Modified: 2018-10-23 04:14:49

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 16, 2018.
FR Citation		83 FR 53488

83 FR 53488 - National Institute of Neurological Disorders and Stroke

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 83, Issue 205 (October 23, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health